Abstract:Thrombotic diseases have been considered major causes of death around the world. Treatments with thrombolytic drugs, such as recombinant tissue-plasminogen activator, urokinase, and streptokinase, are reported to have a life-threatening bleeding tendency. On the contrary, lumbrokinase, identified from Lumbricus rubellus , is specific to fibrin and does not cause excessive bleeding. It possesses fibrinolytic activity and activation of plasminogen to dissolve fibrin. Hence, the purification of fibrinolytic protein monomer from earthworm and antithrombotic evaluation and investigation of mechanisms are needed. In this study, a novel fibrinolytic protein EPF3, with strong fibrinolytic activity, was purified from Pheretima vulgaris by ion exchange and size exclusion chromatography. SDS PAGE, bottom-up proteomics analysis, de novo sequencing, and circular dichroism (CD) analysis were carried out for identification and characterization of it. EPF3, with a molecular weight of 25136.24 Da, consisted of 241 amino acids and contained various forms of secondary structures, including α-helix (3.9%), β-sheet (42.8%), β-turn (21.2%), and random coil (32.1%). It was a trypsin-like serine protease and stable at pH 7.0 to 11.0 and below 40°C. EPF3 was confirmed to possess an antithrombotic effect by ex vivo clot lysis test and fibrinogen-thrombin time (Fib-TT) assay. The three-dimensional structure of EPF3 was predicted by SWISS-MODEL. Molecular docking analysis predicted that EPF3 could directly interact with antithrombotic target proteins (fibrin, fibrinogen, and plasminogen), which was further confirmed by further studies. The antithrombotic mechanism of EPF3 was clarified to be outstanding direct fibrinolysis, fibrinogenolytic activity, and certain activation of plasminogen. EPF3 possesses the potential to be developed into a promising antithrombotic agent.

Development in the Research of Anticoagulant or Thrombolysis Peptide from Protein in Animal and Plant

Bioactive Peptides of Plant Origin: Distribution, Functionality, and Evidence of Benefits in Food and Health

Factor Ⅺ-a promising anticoagulation target

Novel Distribution Pattern of Fibrinolytic Components in Rabbit Tissues Extract: a Preliminary Study

Study on the Cloning and Expression of Human Fibrinogen α ,β, γ Gene

Theaflavin: a Natural Candidate to Restrain Thrombosis

The Research Progress of Direct Thrombin Inhibitors

Pharmaceutical methods of identifying fibrinolytic activity

Production and Functionality of Food-derived bioactive peptides: A review.

Discovering peptide inhibitors of thrombin as a strategy for anticoagulation

Identification and characterization of novel anticoagulant peptide with thrombolytic effect and nutrient oligopeptides with high branched chain amino acid from Whitmania pigra protein

Isolation and Characterization of a Novel Antithrombotic Peptide from Enzymatic Hydrolysate of Agkistrodon acutus Venom

Purification and Characterization of a Novel Anticoagulant Peptide from Protein Hydrolysate of Eupolyphaga sinensis Walker

Hemorrhagic fibrino(geno)lytic enzymes from snake venom

Purification and Characterization of a Novel Antiplatelet Peptide from Deinagkistrodon acutus Venom

Thrombolysis of plasmin and its derivatives:research advances

Thrombin and Thrombin‐Incorporated Biomaterials for Disease Treatments

A Novel Fibrinolytic Protein From Pheretima vulgaris: Purification, Identification, Antithrombotic Evaluation, and Mechanisms Investigation

Progress in Study of Structure-Function Relationship and Protein Engineering of Plasminogen Activators

[Research Development of Chemistry and Bioactive Activity of Plant Peptides].

Research Progress of Plasminogen Activator Inhibitor-1 in Several Diseases